-
We are glad to welcome
@BioIVT as one of our sponsors for 4th Annual Advanced#CellularTherapies Congress in London. Visit: https://bit.ly/2tzwXw9 or write to events@marketsandmarkets.com to know more about sponsorship opportunity#celltherapy#CARTpic.twitter.com/cTcdSsZm8I
-
State of the industry: The financial, clinical and scientific landscape for cell and gene therapies (Janet Lynch Lambert, CEO, ARM); https://bit.ly/2v8MnYy
@CGT_Insights#CellTherapy#GeneTherapy -
Annie Hubert, Senior Director of European Public Policy at ARM, provides an overview of the
#ATMP landscape in Europe at the@GbxSummits#CellTherapy &#GeneTherapy Innovation Summit in Berlin – slides available here: https://buff.ly/2GZ9I1C pic.twitter.com/i4Sl0qrksc
-
A growing trend - Sonoma launches with a $40M Series A to advance regulatory T cell therapy in
#autoimmune and degenerative diseases.#CellTherapy Investors include ARCH, Milky Way, 8VC & Lyell. Notably, the CEO is Jeff Bluestone (UCSF/Parker Institute). https://www.prnewswire.com/news-releases/sonoma-biotherapeutics-launches-with-40-million-in-series-a-funding-to-advance-regulatory-t-cell-therapy-in-autoimmune-and-degenerative-diseases-300999810.html …Prikaži ovu nit -
#celltherapy followed by#SouldFood and Most DEFINITELY#GetRichToThis -
Now online our new work on methods for tracking
#celltherapy products in patients. https://www.nature.com/articles/s41409-020-0822-8 … -
Listen to Nkarta Therapeutics' CSO James Trager talk about the company's
#CellTherapy platform on February 18, 2020.@bio2device https://bio2devicegroup.org/events/allogeneic-natural-killer-cells-engineered-to-beat-cancer/ … -
CD19
#CAR NK-#celltherapy achieves 73% response rate in patients with leukemia and lymphoma@nejmhttps://medicalxpress.com/news/2020-02-cd19-car-nk-cell-therapy-response.html … -
#CellTherapy There will be a time when you just have to take a deep breath, relax, and let things go. Focus on what and who really matters to you and the rest will work itself out... I Am S.C. Yatta Follow me on Facebook Instagram and Twitter @ S.C. Yatta -
4 hacks that allow you to push patient safety during cell and gene therapies to the next level. Check out our http://CGT.STREAM – our logistical solution for a successful CAR-T cell therapy! _________ https://ecs.page.link/MjDF9
#celltherapy#genetherapypic.twitter.com/r7UAULYvtU
-
PACT Pharma strives to expand their manufacturing operations of
#CellTherapy products, raising $75 million in their Series C financing round. Read about how they plan to develop new cell therapies that target solid tumors ==>http://bit.ly/PACTCellTher#biotech#healthcarepic.twitter.com/XFSU9h0YnT
-
Tmunity is committed to our relentless pursuit of restoring hope for cancer patients worldwide
#WorldCancerDay2020
#Tmunitytx#CellTherapy -
With $315M
@MaSTherCell acquisition,@CatalentPharma eyes growth in#celltherapy development, manufacturing: http://ow.ly/XVk750ydnPz pic.twitter.com/AlNtJvYwWt
-
All set up and ready for the next couple of days at the cell and gene therapy innovation meeting in Berlin
#CellTherapy#viralvectors @biotechnepic.twitter.com/yU9jG2OOHj
-
These talks have been broken up into bite-sized pieces - if you have 15-30 minutes, you can watch one of these webinars from our wonderful supply chain and logistics speakers!
#CellTherapy#GeneTherapyhttps://twitter.com/CCRM_ca/status/1224771407936217090 …
-
Mesenchymal stromal/stem cell (
#MSC) genomic integrity: New digital PCR test from#stemgenomics#stemcell#celltherapy#regenerativemedicine https://stemgenomics.com/mesenchymal-stromalstem-cell-msc-genomic-integrity-new-digital-pcr-test …pic.twitter.com/DxaBDYDU24
-
Catalent To Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform Read more: http://ow.ly/jawX50ybOMV
#pressrelease#celltherapy pic.twitter.com/BfpOGHkxz3
-
Orgenesis sells Masthercell Global, its contract development and manufacturing organisation subsidiary. Will use $127 million to continue to grow its point-of-care
#celltherapy business and to further the development of its#ATMPs. https://tinyurl.com/whfbu7u -
Register for our exclusive Bioanalysis Zone Coffee Chat focusing on developments in cell and gene therapies featuring Frontage's expert, Weiping Shao!
#CellTherapy#GeneTherapy Register, here: http://bit.ly/2Uw5nLt pic.twitter.com/Y3s6HZ8lyD
-
Lineage is developing a novel
#celltherapy to treat dry age-related macular degeneration (#AMD), the leading cause of irreversible vision loss in the US. OpRegen is currently in Phase I/IIa and has the potential to help many patients. https://investor.lineagecell.com/news-releases/news-release-details/lineage-provides-update-patient-enrollment-phase-iiia-clinical …pic.twitter.com/hxZ6YjG9v3
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.